| 生物活性 | |||
|---|---|---|---|
| 靶点 |
|
||
| 描述 | Escitalopram oxalate, the S-enantiomer of racemic citalopram, is a selective serotonin reuptake inhibitor (SSRI) with a Ki of 0.89 nM. It has approximately 30 times higher binding affinity than its R(-)-enantiomer and exhibits selectivity over both the dopamine and norepinephrine transporters. Escitalopram oxalate is used in the study of major depression[1][2]. | ||
| 临床研究 | |||||
|---|---|---|---|---|---|
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00668525 | Major Depressive Disorder | Phase 3 | Completed | - | - |
| NCT00668525 | - | Completed | - | - | |
| NCT01398514 | Fear Conditioning | Phase 4 | Completed | - | - |
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
2.41mL 0.48mL 0.24mL |
12.06mL 2.41mL 1.21mL |
24.13mL 4.83mL 2.41mL |
| 参考文献 |
|---|